EAY131 Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Start Date:
June 30, 2018
IRB Number:
https://clinicaltrials.gov/ct2/show/NCT02465060
Condition/Disease:
Cancer - Lymphoma,
Cancer - Brain,
Cancer - Breast,
Cancer - Gastric,
Cancer - Colorectal,
Cancer - Esophageal,
Cancer - Bladder,
Cancer - Prostate,
Cancer - Ovarian,
Cancer - Head and Neck,
Cancer - Lung,
Cancer - Melanoma,
Cancer - Pancreatic,
Cancer - Rare,
Cancer - Sarcoma,
Cancer - Thyroid
Purpose of Research:
CANCER, ADVANCED, REFRACTORY, SOLID TUMOR, LYMPHOMA, MULTIPLE MYELOMA, MYELOMA, BRAIN, BREAST, LUNG, COLORECTAL, HEAD, NECK, PANCREAS, GASTROINTESTINAL, PROSTATE, BLADDER, CERVICAL, OVARIAN, KIDNEY, GENITOURINARY, ENDOMETRIAL, UTERINE, MELANOMA, THYROID, GALLBLADDER, SARCOMA, GASTRIC
Status:
Accepting Participants
